What knee osteoarthritis does — and why it is so common in older adults

Being told you have knee osteoarthritis can feel like a heavy verdict — as though the damage is done and things will only get worse. That is not what the evidence shows, and it is worth understanding what the diagnosis actually means before drawing conclusions about your future.

Knee osteoarthritis develops when the cartilage lining the joint gradually thins and breaks down, allowing the underlying bone to remodel, form bony spurs (osteophytes), and narrow the joint space. The process is progressive but rarely linear — many people experience long stretches of relative stability punctuated by flares, rather than a steady decline.

Globally, roughly 23% of adults aged 40 and over are affected, making it one of the leading causes of chronic musculoskeletal disability in older adults. Contributing factors include age, excess body weight, previous knee injury, muscle weakness, and the way load is distributed through the joint — several of which can be directly modified with the right support.

One of the most important things to understand is that X-ray or MRI findings do not reliably predict how much pain or limitation a person will experience. Some people carry significant structural changes with relatively mild symptoms; others have marked pain despite modest imaging findings. The scan is one piece of information, not a verdict on what daily life will look like.

Conservative care — exercise, weight management, education, and appropriate symptom control — is not a waiting room for surgery. OARSI 2019, NICE NG226, and the ACR/AF 2020 guidelines all designate it the mandatory first pathway, backed by substantial trial evidence. For most people, it is where meaningful, lasting improvement happens.

Exercise and physiotherapy: the cornerstone of the conservative window

Structured exercise is not a vague lifestyle suggestion — it is the intervention with the strongest evidence base in the conservative management of knee OA, and the one that delivers the most durable benefit.

A 2025 BMJ network meta-analysis drawing on 217 randomised controlled trials and 15,684 participants found that aerobic exercise produces large improvements in knee OA pain at both short- and mid-term follow-up (standardised mean difference −1.10 and −1.19 respectively), with moderate-certainty evidence throughout. Strengthening and mixed-modality programmes add a different dimension: large functional gains at mid-term, making them essential for patients whose primary concern is what their knee lets them do day-to-day.

Critically, the modality matters less than how the exercise is delivered. Adherence is the primary driver of outcome in resistance exercise for knee OA, and adherence is substantially higher in supervised, structured programmes than in unsupervised exercise. For older adults in particular, supervised physiotherapy offers more than motivation — it provides progressive load management, technique correction, and timely modification when pain flares, all of which an independent home programme cannot reliably replicate.

The comparison with injection therapy makes this point concrete. A 2020 NEJM randomised controlled trial by Deyle et al. found that physical therapy delivered meaningfully more durable functional benefit over 12 months than corticosteroid injection alone. The clinical implication is straightforward: injection has a legitimate short-term role during acute flares, but it is a complement to physiotherapy, not a substitute for it.

Patient education — understanding how load affects the joint, how to modify activity without deconditioning, and why consistent engagement with a programme matters — is designated a Core Treatment alongside exercise in the OARSI 2019 guidelines. It is not an adjunct; it is part of what makes the exercise component work.

Weight management, medications, and injections within the conservative pathway

Weight management stands apart from other supporting modalities in one important respect: it acts on the underlying biomechanical load that drives OA progression, not only the symptoms. A 2024 NEJM randomised controlled trial of semaglutide 2.4 mg weekly in obese adults with moderate knee OA found a 41.7-point reduction in WOMAC pain scores compared with 27.5 points in the placebo group (p<0.001), alongside 13.7% body weight loss over 68 weeks. The trial population was defined by obesity rather than by knee OA severity alone, so the results should not be extrapolated unreservedly — but they represent some of the most striking pain-relief data in recent conservative-care literature, and they reinforce weight reduction as a genuine treatment priority rather than a lifestyle footnote.

For pharmacological symptom control, topical NSAIDs — such as diclofenac gel — are the preferred option for knee OA in older adults. OARSI 2019 designates them Level 1A for knee OA, and their favourable gastrointestinal and cardiovascular safety profile makes them substantially better tolerated than oral formulations in this age group. Oral NSAIDs are not ruled out entirely, but in older adults with cardiovascular disease, renal impairment, or frailty, major guidelines advise against them. Anyone currently taking an oral NSAID for knee pain is best served by discussing the risk-benefit balance with their prescriber rather than stopping abruptly.

Intra-articular injections fill two distinct roles within the conservative pathway. Corticosteroid injections are appropriate for managing acute flares — they provide meaningful short-term pain relief but are not disease-modifying, and clinical caution applies to repeat administration over time. Hyaluronic acid (viscosupplementation) occupies a different position: a guideline-eligible bridge option in early-to-moderate disease, with modest benefit typically peaking around 6–8 weeks post-injection and limited supporting evidence once disease reaches the end stage.

Glucosamine is not strongly recommended by major guidelines, including OARSI 2019 and NICE NG226. Platelet-rich plasma and other orthobiologics are under active investigation, but current evidence remains insufficient to position them within the standard conservative pathway.

Why one approach does not fit all patients — personalising the conservative plan

Not every older adult with knee OA faces the same risk profile — and that matters when deciding which conservative modalities are safe and most appropriate. OARSI 2019 takes a comorbidity-stratified approach: cardiovascular status, frailty, BMI, and psychosocial factors such as pain catastrophising all influence treatment prioritisation, rather than a uniform step-ladder applied to everyone.

For patients with significant frailty or complex polypharmacy, the pharmacological window can be genuinely narrow. Oral NSAIDs are contraindicated across much of this group, and even topical formulations warrant care when multiple medications are in play. This is partly why exercise and weight management carry additional clinical weight in this population — they are the modalities least constrained by competing drug interactions or cardiovascular caution.

It is worth acknowledging a limitation in the underlying evidence: most large knee OA trials do not separate adults aged 65 and over from the broader adult population. The guidance applied to older patients is well-supported by consensus and extrapolation from high-quality data, but it is not always directly derived from this age group. Specialist assessment helps close this gap — a clinician reviewing imaging, comorbidities, and functional capacity together can apply the available evidence to an individual rather than a generic protocol.

Biomechanical factors add a further layer of personalisation. Altered gait mechanics and uneven joint-compartment loading influence where OA stress concentrates and how symptoms evolve. Objective computerised gait analysis — available at Lincolnshire Knee via MAI Motion® — can identify these contributors and refine an exercise prescription to address the specific mechanical pattern of each patient.

One route can be firmly ruled out. A 2024 systematic review and meta-analysis of ten randomised controlled trials found no difference between arthroscopic knee surgery and conservative management on pain, WOMAC function, or patient satisfaction — arthroscopy is not a bridge between conservative care and joint replacement, and it does not belong in a personalised conservative plan.

When conservative care is no longer enough — recognising the escalation threshold

Three months of structured, supervised, adherent conservative care without adequate symptom relief is a reasonable trigger for surgical referral — the British Orthopaedic Association anchors its guidance here, while clinical consensus often extends that window to six months depending on trajectory and the patient's preference. The operative word is structured: a handful of physio sessions attended inconsistently does not count as a failed conservative pathway.

The clinical signs that support escalation form a recognisable cluster. Persistent night pain that regularly disrupts sleep is one of the clearest signals — pain at rest, removed from loading and movement, suggests disease that conservative modalities can no longer manage adequately. Difficulty completing basic daily tasks such as walking a reasonable distance or climbing a flight of stairs points in the same direction, as does joint instability or progressive deformity. Any one of these, alongside documented failure of a structured conservative programme, is enough to raise the question of surgical referral with your clinician.

A note on imaging: a severe X-ray alone does not make surgery the next step. Kellgren-Lawrence grading informs the clinical picture but symptoms must align — the decision rests on what a patient can and cannot do, not on radiographic severity in isolation.

Total knee replacement (TKR) is the established surgical endpoint for advanced knee OA that has not responded to conservative care. Demand is projected to rise substantially through 2030 as the population ages and obesity rates climb. Every patient who genuinely benefits from a further period of well-structured conservative care represents one fewer addition to an already-pressured elective surgical list — which is why optimising that window matters beyond any one individual.

The precise sequence and duration of conservative modalities before escalation has not been resolved by any current guideline. But a practical heuristic holds: if you have completed at least three months of supervised physiotherapy consistently, pain still prevents ordinary tasks such as managing stairs, and rest pain is disturbing your sleep, that combination provides a clear basis for requesting a formal surgical assessment.

What a specialist assessment involves and when to seek one

If conservative care has been running for several weeks without meaningful progress — or if pain is worsening despite a structured programme — a specialist consultation offers something a standard GP appointment rarely can: a joined-up review of clinical history, physical examination, and imaging, considered together in one setting.

The examination covers the practical markers: range of motion, joint alignment, ligament stability, and the presence of effusion. Imaging review follows, typically beginning with weight-bearing X-rays. Where soft-tissue or cartilage detail matters — to gauge compartment involvement or confirm the structural stage of disease — MRI adds precision. Lincolnshire Knee's onMRI™ platform applies AI-driven analysis to knee MRI scans, including cartilage and meniscus segmentation and T2 mapping, yielding structural data more granular than conventional reporting.

Biomechanical assessment is a complementary strand. Computerised gait analysis via MAI Motion® can identify how load is distributed across the knee — information that directly shapes exercise prescription and may highlight alignment contributors that respond to non-surgical correction.

Patients do not need a GP referral to be seen, and there are no NHS-style waiting lists. Lincolnshire Knee is part of the MSK Doctors group and accepts patients without referral. Book an assessment at lincolnshireknee.co.uk.

The most common outcome of a first consultation is not a surgical recommendation. It is a clearer, better-personalised conservative plan — with explicitly agreed criteria for when escalation would become the appropriate next step.

1. [1] Comparative efficacy and safety of exercise modalities in knee osteoarthritis: systematic review and network meta-analysis (BMJ, 2025). (2025). https://doi.org/10.1136/bmj-2025-085242 https://doi.org/10.1136/bmj-2025-085242
2. [2] Effects of Resistance Exercise on Pain and Function in Knee and Hip Osteoarthritis: Systematic Review and Meta-Analysis (2024). (2024). https://doi.org/10.1002/acr.25313 https://doi.org/10.1002/acr.25313